Epizyme Appoints Oncology Industry Leader Michael Giordano, MD, to its Board of Directors

CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced the appointment of Michael Giordano, M.D., to the company's board of directors . Dr. Giordano brings to the ...
Login to comment.